Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Miguel Materin, MD, Assistant Professor of Ophthalmology, Director of Ocular Oncology Section Yale University School of Medicine, describes uveal melanoma, a rare cancer but the most common cause…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses Barrett’s esophagus and its identification and treatment in the primary care…
NEW YORK (Reuters Health) – Liver transplant recipients whose indication for transplant was hepatitis C virus (HCV) cirrhosis have markedly poorer survival compared to patients transplanted for alcoholic…
NEW YORK (Reuters Health) – The tyrosine kinase inhibitor gefitinib is more effective than standard therapy with carboplatin-paclitaxel for lung adenocarcinomas with mutations in the epidermal growth factor…
NEW YORK (Reuters Health) – Roughly 56% of melanomas detected in general dermatology practice are found through full-body skin examinations (FBSE), not as the result of patient complaint,…
NEW YORK (Reuters Health) – In general, the quadrivalent human papillomavirus vaccine (qHPV, Gardasil, Merck and Co.) licensed by the US Food and Drug Administration in June 2006…
NEW YORK (Reuters Health) – A longer atrial fibrillation (AF) cycle length, measured with surface ECG, predicts successful catheter ablation in patients with this common arrhythmia, new research…
NEW YORK (Reuters Health) – In children in the ER, use of ketamine at a high IV dose increases the risks of airway and respiratory events, emesis, and…
NEW YORK (Reuters Health) – Contrary to common belief, a systematic review has found that elective induction of labor at or beyond 41 weeks of gestation may reduce…
NEW YORK (Reuters Health) – The use of ACE inhibitors prior to coronary artery bypass grafting (CABG) is associated with an increased risk of death, need for inotropic…
